companydata.dkNovo Nordisk Research Center Gladsaxe ApS: Financial statements 2022
CVR: 39119374
Novo Nordisk Research Center Gladsaxe ApS (CVR 39119374) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 379,438 and a net result of DKK -8,830,214 compared with DKK -6,196,311 the year before. Equity amounted to DKK -5,889,294. The company had 4 employees in the financial year.
- Gross Profit
- 379,438 kr.
- Profit/Loss
- -8,830,214 kr.
- Equity
- -5,889,294 kr.
- Total Assets
- 7,777,195 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 379 t. | -8.8 mio. | -5.9 mio. | 4 |
| 2021 | - | 0 | -6.2 mio. | 2.9 mio. | 3 |
| 2020 | - | 10.7 mio. | 3.2 mio. | 9.5 mio. | 5 |
| 2019 | - | 25.6 mio. | 14.4 mio. | 18.3 mio. | 5 |
| 2018 | - | 14.9 mio. | 9.8 mio. | 52 t. | 1 |
Keep an eye on Novo Nordisk Research Center Gladsaxe ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Novo Nordisk Research Center Gladsaxe ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK -6,196,311.
About Novo Nordisk Research Center Gladsaxe ApS
Novo Nordisk Research Center Gladsaxe ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Embark Biotech ApS and Embark Biotech IvS. The management consists of Rikke Ryttergaard Andersen. The company is owned by NOVO NORDISK A/S. The company has 7 employees. In 2025, the company reported a gross profit of DKK -1,000 and a net result of DKK 48,000 compared with DKK 6,174,000 the year before. Equity amounted to DKK 807,000.